// App-Quantinova.ai

i125 : The past: conventional immunosuppression: lessons from the European Scleroderma Observational Study (ESOS)

Researchers

Presenter

  • Ariane L Herrick

Principal Investigators

  • N/A

Medical Centers

  • Rheumatology Department, Salford Royal NHS Foundation Trust, Manchester, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Pulmonary fibrosis

  • Scleroderma

  • Mental retardation, X-linked, syndromic, 15

Biomarkers

  • N/A

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Mycophenolic acid

  • Methotrexate

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved